©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114309
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114309
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114309
Table 1 Criteria for recurrence and case distribution
| Criterion for recurrence | Number of cases | Percentage (%) |
| Imaging (CT or PET/CT) revealing new masses within the primary surgical field | 15 | 38.5 |
| Imaging (CT or PET/CT) detecting space-occupying lesions in other organs (distant metastasis), with primary tumors excluded | 12 | 30.8 |
| Confirmation of recurrence via gastroscopy and pathological biopsy (local recurrence) | 8 | 20.5 |
| Confirmation of recurrence through reoperation or exploratory surgery | 2 | 5.1 |
| Presence of uncontrollable hemorrhagic ascites, or detection of cancer cells in ascites cytology (peritoneal carcinomatosis) | 2 | 5.1 |
| Total | 39 | 100 |
- Citation: Duan XX, Yu X, Zhou L. Timeliness of postoperative serum carcinoembryonic antigen monitoring for predicting recurrence after gastric cancer surgery. World J Gastrointest Surg 2026; 18(1): 114309
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/114309.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.114309